Waste Energy Corp Names New CFO
Company Announces Full Repayment of Convertible Note
FAIRFIELD, CA / ACCESS Newswire / March 6, 2025 / Waste Energy Corp ('Waste Energy' or the 'Company'), (OTCQB:WAST), an emerging waste-to-energy (WTE) company at the forefront of sustainable innovation, dedicated to diverting plastic and tires waste streams from oceans, streams, nature and food supplies, today announced the appointment of Mr. Braden Glasbergen as its new Chief Financial Officer (CFO), effective immediately. Mr. Glasbergen has played a pivotal role in the company's financial operations for several years, assisting with its SEC filings and working closely under the guidance of outgoing CFO, Mr. Swapan Kakumanu.
With over two decades of experience in financial leadership roles across industries such as manufacturing, consulting, and environmental services, Glasbergen brings a wealth of expertise to his new position. His strategic financial acumen, combined with his deep understanding of regulatory compliance, corporate governance, and operational efficiency, makes him an ideal fit to lead Waste Energy Corp's financial strategy as the company continues to expand its waste-to-energy initiatives.
'I couldn't be more thrilled to welcome Mr. Braden Glasbergen as our new CFO,' said Scott Gallagher, Chairman and CEO of Waste Energy Corp. 'His strong financial background and deep understanding of our business will be invaluable as we continue driving growth and innovation in the waste to energy sector. As we scale our business, we remain focused on driving shareholder value and ensuring long-term financial stability. We have assembled a leadership team that values our presence in the public markets and is committed to protecting our capital structure and driving shareholder value as we grow. We will continue to make strategic decisions that align with our mission of expanding our operations while maintaining strong financial discipline and Braden will play an important role in that process.'
As the company welcomes Mr. Glasbergen in his new role, it extends its sincere gratitude to Mr. Swapan Kakumanu for his years of dedicated service. Kakumanu played an instrumental role in transitioning the company toward its waste-to-energy business model, and his contributions have laid a strong foundation for future success.
'On behalf of the entire team at Waste Energy Corp, I want to personally thank Swapan for his service and leadership throughout the years,' added Gallagher. 'His dedication and expertise has been critical in shaping the company's financial direction, especially during the transition and we appreciate his efforts in ensuring a smooth transition.'
In response, Mr. Kakumanu expressed his confidence in the company's direction, stating, 'I firmly believe in the long-term potential of Waste Energy Corp and its mission to revolutionize waste-to-energy solutions. The company is positioned for significant growth, and I have no doubt that Braden and the leadership team will continue executing on our vision. I look forward to supporting the team as a consultant as needed, ensuring continuity and contributing to the company's success in any way I can.'
Additionally, Waste Energy Corp is pleased to announce that a previously issued convertible note has been fully repaid. This milestone reflects the company's commitment to maintaining financial discipline and maximizing shareholder value as it continues to develop innovative energy solutions.
Furthermore, the company has begun the process of permitting and securing regulatory filings to handle plastic and tire waste at the federal level as it evaluates opportunities in several states. This initiative aligns with Waste Energy Corp's long-term growth strategy as it seeks to scale its business and expand its waste-to-energy operations nationwide. Glasbergen will play a key role in this effort, working alongside President of Waste-to-Energy Operations W. Scott McBride to navigate the permitting process and ensure regulatory compliance as the company expands its footprint.
For more information about Waste Energy Corp, please visit www.WasteEnergyCorp.com.
Company Contact:
Scott Gallagher, CEO
(727) 417-7807
[email protected]
About Waste Energy Corp
Waste Energy Corp is committed to redefining waste as an asset and to reducing the volume of non-recyclable waste in landfills and incinerators. Specializing in the conversion of waste plastics and used tires into clean diesel fuel. The company will combine AI & Pyrolysis technologies to reduce the volume of plastic and tire waste in landfills while developing a new, clean, US based energy source.
Waste Energy Corp. trades on the OTCQB market, over the counter under the ticker symbol: WAST. Waste Energy Corp is an SEC exchange act, fully reporting company. For more information on Waste Energy Corp, please visit www.WasteEnergyCorp.com. For additional investor or financial information visit: www.SEC.gov.
Forward-Looking Statements
This press release contains forward-looking statements regarding Waste Energy Corp's business operations and future financial performance and projections. These statements are subject to various risks and uncertainties, including market conditions and regulatory approvals and other factors outside of the control of WEC, which may impact the actual results. Investors are encouraged to review all risk factors and results disclosed in the company's public filings with the Securities and Exchange commission at www.SEC.Gov.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
an hour ago
- Indianapolis Star
Galley Solutions Unveils 'Galley Assist,' the First Domain‑Specific LLM Built Exclusively for Foodservice
AI‑powered importer slashes recipe data‑entry time by 75%+, accelerating menu innovation for enterprise kitchens. SAN DIEGO, CA / ACCESS Newswire Galley Solutions, the leading Culinary Resource Planning (CRP) platform, today announced the general availability of Galley Assist, the AI interface to its CRP platform powered by the industry's first large‑language model (LLM) trained solely on structured culinary data. Unlike generic GPT‑based tools, Galley Assist 'speaks food' natively, instantly converting unstructured content- PDFs, spreadsheets, even photos of a menu board- into fully costed, allergen‑tagged recipes inside the Galley platform. The AI‑powered importer significantly reduces recipe data-entry, empowering enterprise kitchens to accelerate their menu-development process. In fact, early pilot kitchens report time savings of more than 75 percent on recipe creation, freeing culinary teams to focus on creativity instead of manual inputting. One multi‑site program reduced the admin required to import a 15‑recipe menu from two hours to just 30 minutes. 'Operators shouldn't have to choose between creativity and data integrity,' said Benji Koltai, Galley's co‑founder and CEO. 'Galley Assist collapses that trade‑off by turning messy source files into production‑ready recipes in seconds, all while preserving the rigorous cost and nutrition controls our customers rely on.' Capabilities available today: Instant Recipe Import & Creation – Drag‑and‑drop ingestion or natural‑language generation with costs and nutrition auto‑calculated. Auto‑ingredient matching – 80+ percent of ingredients map to a customer's existing taxonomy out of the gate; any new items are flagged for review to prevent database clutter. Sub‑recipe detection – Identifies and links component recipes automatically, ensuring accurate roll‑up costing and nutrition. Capabilities to come: Bulk Upload – Mass‑convert entire recipe libraries overnight. Menu Importer – Ingest multi‑day, multi‑location menus and build underlying recipes automatically, complete with serving dates for downstream nutrition software. Nutrition‑Facts Panel Builder – Generate compliant labels on the fly, eliminating weeks of R&D work. Galley is currently conducting structured interviews with early adopters across corporate dining, event catering, higher‑education foodservice, and hospitality. Preliminary ROI metrics, including hours saved per week, reduction in ingredient‑database errors, and menu‑launch cycle times, will be released later this summer. About Galley Solutions Galley Solutions is the Culinary Resource Planning platform that helps foodservice operators control costs, streamline production, and unlock structured recipe data at scale. From single‑unit kitchens to global multi‑concept brands, Galley provides the digital foundation for profitable, data‑driven food operations. Media Contact Ian Christopher Hello@ SOURCE: Galley Solutions, Inc. View the original press release on ACCESS Newswire
Indianapolis Star
2 hours ago
- Indianapolis Star
New to The Street's Featured Client - Roadzen's DrivebuddyAI(TM) Platform Recognized as Key Innovator in InCabin Market Map Report
NEW YORK CITY, NEW YORK / ACCESS Newswire Roadzen Inc. (NASDAQ:RDZN), a global leader at the intersection of artificial intelligence, insurance, and mobility, today announced that its flagship AI-powered platform, DrivebuddyAI™, has been prominently featured in the latest InCabin Market Map Report. The report, released in advance of InCabin USA 2025 in Detroit-the premier event for driver and occupant monitoring technologies-spotlights DrivebuddyAI™ as a key innovator shaping the future of intelligent in-cabin safety and automation. DrivebuddyAI™ is Roadzen's cutting-edge platform combines proprietary AI, computer vision, and driver behavioral analytics to deliver real-time risk driver assessments and coaching to create safer conditions and more efficient outcomes for fleet operators. Its patented technology generates actionable insights for insurers and fleet operators, drawing from diverse environments to create precise risk profiles. Already deployed by several major logistics fleets and certified by ARAI in India, DrivebuddyAI's recognition by InCabin underscores its growing relevance in the global mobility and automotive landscape. 'We are honored that DrivebuddyAI™ is being recognized among the most transformative in-cabin technologies globally,' said Rohan Malhotra, CEO of Roadzen. 'As we scale across the U.S., Europe, and Asia, our focus remains on deploying AI that can reduce accidents, optimize insurance, and unlock the next generation of driver-assist systems.' Nisarg Pandya, Head of DrivebuddyAI commented, 'We've built an AI driver that's been rigorously tested in India-one of the most complex and unpredictable driving environments in the world. Our technology has matured through deployment with logistics fleets that demanded real-world results and ROI-and we delivered it, achieving a 72% reduction in accidents in over 1.8 billion kilometers of real-world driving.' Roadzen's inclusion in the InCabin Market Map Report coincides with increasing global demand for AI-powered driver safety solutions, especially as regulators, insurers, and automakers seek reliable platforms to meet evolving standards in vehicle automation and occupant protection. About Roadzen Inc. Roadzen (NASDAQ:RDZN) is transforming global mobility through its proprietary AI technologies that enable smarter auto insurance, safer driving, and autonomous vehicle innovation. Operating in North America, Europe, and Asia, Roadzen's platforms combine computer vision, telematics, and data science to deliver next-gen mobility solutions for insurers, OEMs, and fleet operators. To learn more, visit Media Contact Monica@
Yahoo
3 hours ago
- Yahoo
Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
PEACHTREE CORNERS, Ga., June 10, 2025--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a purchase order and first payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT) for 35 LuViva systems. HDMT will order directly from Guided Therapeutics and the devices will be assembled and tested by Guided Therapeutics' Chinese partner, Shandong Yaohua Medical Instrument Corporation (SMI). HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive gynecology products provider for 42 hospitals that perform approximately two million cervical cancer screenings annually. Said Yang Dongye, CEO of HDMT: "We are extremely impressed with the performance of LuViva and our goal is to eventually replace the current screening tests with LuViva." The purchase order for $700,000 is to supply HDMT with 35 systems over the next eight months starting in July of this year. "We are extremely pleased to be working with HDMT to bring LuViva to Zhejiang Province and anticipate making initial shipments next month," added Mark Faupel, Guided Therapeutics' CEO. "Working directly with an exclusive provider of gynecology products that can potentially conduct two million LuViva tests each year is a major advance for GTI." About Guided Therapeutics Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company's first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc. Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics' actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading "Risk Factors" in Guided Therapeutics' reports filed with the SEC, including Guided Therapeutics' Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and subsequent filings. View source version on Contacts Mark FaupelGuided Therapeutics770-242-8723
